Country: Amerika Syarikat
Bahasa: Inggeris
Sumber: NLM (National Library of Medicine)
DICLOFENAC POTASSIUM (UNII: L4D5UA6CB4) (DICLOFENAC - UNII:144O8QL0L1)
Golden State Medical Supply, Inc.
ORAL
PRESCRIPTION DRUG
Carefully consider the potential benefits and risks of diclofenac potassium tablets and other treatment options before deciding to use diclofenac potassium tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS: Gastrointestinal Bleeding, Ulceration, and Perforation). Diclofenac potassium tablets are indicated: - For treatment of primary dysmenorrhea - For relief of mild to moderate pain - For relief of the signs and symptoms of osteoarthritis - For relief of the signs and symptoms of rheumatoid arthritis Diclofenac potassium tablets are contraindicated in the following patients: - Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to diclofenac or any components of the drug product (see WARNINGS: Anaphylactic Reactions, Serious Skin Reactions). - History of asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, sometimes fat
Diclofenac Potassium Tablets, USP 50 mg are available for oral administration as light brown, round shaped, unscored, film coated tablets, imprinted “AMI” on one side and “DP” over “50” on the other side. They are supplied as follows: Bottles of 100 NDC 51407-443-01 Dispense in a tight, light-resistant container as defined in the USP using a child resistant closure. Keep container tightly closed. Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Protect from moisture. PHARMACIST: Dispense a Medication Guide with each prescription. AMICI PHARMACEUTICALS LLC. DICLOFENAC POTASSIUM TABLETS, USP 50 mg Distributed by: Amici Pharmaceuticals LLC. Melville, NY 11747 Revision date: March 2021 Marketed by: GSMS, Inc. Camarillo, CA 93012 USA
Abbreviated New Drug Application
Golden State Medical Supply, Inc. ---------- MEDICATION GUIDE FOR NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS ) What is the most important information I should know about medicines called Nonsteroidal Anti- Inflammatory Drugs (NSAIDs)? NSAIDs can cause serious side effects, including: • Increased risk of a heart attack or stroke that can lead to death. This risk may happen early in treatment and may increase: •with increasing doses of NSAIDsowith longer use of NSAIDs Do not take NSAIDs right before or after a heart surgery called a “coronary artery bypass graft (CABG)”. Avoid taking NSAIDs after a recent heart attack, unless your healthcare provider tells you to. You may have an increased risk of another heart attack if you take NSAIDs after a recent heart attack. • Increased risk of bleeding, ulcers, and tears (perforation) of the esophagus (tube leading from the mouth to the stomach), stomach and intestines: •any time during use •without warning symptoms •that may cause death The risk of getting an ulcer or bleeding increases with: •past history of stomach ulcers, or stomach or intestinal bleeding with use of NSAIDs •taking medicines called “corticosteroids”, “anticoagulants”, “SSRIs” or “SNRIs” •increasing doses of NSAIDs •longer use of NSAIDs •smoking •drinking alcohol •older age •poor healthoadvanced liver disease •bleeding problems NSAIDs should only be used: •exactly as prescribed •at the lowest dose possible for your treatment of or the shortest time needed What are NSAIDs? NSAIDs are used to treat pain and redness, swelling, and heat (inflammation) from medical conditions such as different types of arthritis, menstrual cramps, and other types of short-term pain. Who should not take NSAIDs? Do not take NSAIDs: •if you had an asthma attack, hives, or other allergic reaction with aspirin or any other NSAIDs. •right before or after heart bypass surgery. Before taking NSAIDs, tell your healthcare provider about all of your medical conditions, includi Baca dokumen lengkap
DICLOFENAC POTASSIUM- DICLOFENAC POTASSIUM TABLET, FILM COATED GOLDEN STATE MEDICAL SUPPLY, INC. ---------- DICLOFENAC POTASSIUM TABLETS, USP 50MG WARNING: RISK OF SERIOUS CARDIOVASCULAR AND GASTROINTESTINAL EVENTS CARDIOVASCULAR THROMBOTIC EVENTS NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) CAUSE AN INCREASED RISK OF SERIOUS CARDIOVASCULAR THROMBOTIC EVENTS, INCLUDING MYOCARDIAL INFARCTION AND STROKE, WHICH CAN BE FATAL. THIS RISK MAY OCCUR EARLY IN TREATMENT AND MAY INCREASE WITH DURATION OF USE (SEE WARNINGS). DICLOFENAC POTASSIUM TABLETS ARE CONTRAINDICATED IN THE SETTING OF CORONARY ARTERY BYPASS GRAFT (CABG) SURGERY (SEE CONTRAINDICATIONS, WARNINGS). GASTROINTESTINAL BLEEDING, ULCERATION, AND PERFORATION NSAIDS CAUSE AN INCREASED RISK OF SERIOUS GASTROINTESTINAL (GI) ADVERSE EVENTS INCLUDING BLEEDING, ULCERATION, AND PERFORATION OF THE STOMACH OR INTESTINES, WHICH CAN BE FATAL. THESE EVENTS CAN OCCUR AT ANY TIME DURING USE AND WITHOUT WARNING SYMPTOMS. ELDERLY PATIENTS AND PATIENTS WITH A PRIOR HISTORY OF PEPTIC ULCER DISEASE AND/OR GI BLEEDING ARE AT GREATER RISK FOR SERIOUS GI EVENTS (SEE WARNINGS). DESCRIPTION Diclofenac potassium tablets, USP are a benzeneacetic acid derivative. Diclofenac potassium tablets, USP are available as tablets of 50 mg (light brown) for oral administration. The chemical name is 2-[(2,6-dichlorophenyl)amino] benzeneacetic acid, monopotassium salt. The molecular weight is 334.25. Its molecular formula is C H C NKO , and it has the following structural formula: Each diclofenac potassium tablet, USP intended for oral administration, contains 50 mg diclofenac potassium for oral administration. In addition, each tablet contains the following inactive ingredients: colloidal silicon dioxide, hydroxyethyl cellulose, iron oxide red, magnesium stearate, methanol, polyethylene glycol, povidone, sodium bicarbonate, 14 10 l2 2 titanium dioxide and yellow iron oxide. CLINICAL PHARMACOLOGY MECHANISM OF ACTION Diclofenac has analgesic, anti-inflammatory, and antipyretic properties. The mechan Baca dokumen lengkap